No Data
No Data
Theriva Biologics Downgraded to Hold From Buy at Maxim
Medicus Pharma Price Target Raised to $20 From $10 at Maxim
Express News | Maxim Group Downgrades Theriva Biologics to Hold
Market Chatter: Singapore's HDB Resale Prices Jump 9.3% in April
Maxim Group Maintains Buy on Vivid Seats, Lowers Price Target to $3
Malaysia Property Sector's Long-Term Outlook Remains Positive -- Market Talk